Literature DB >> 19775827

Impact of incidental irradiation on clinically uninvolved nodal regions in patients with advanced non-small-cell lung cancer treated with involved-field radiation therapy: does incidental irradiation contribute to the low incidence of elective nodal failure?

Tomoki Kimura1, Taro Togami, Yoshihiro Nishiyama, Motoomi Ohkawa, Hitoshi Takashima.   

Abstract

PURPOSE: To evaluate the incidental irradiation dose to elective nodal regions in the treatment of advanced non-small-cell lung cancer with involved-field radiation therapy (IF-RT) and the pattern of elective nodal failure (ENF). METHODS AND MATERIALS: Fifty patients with advanced non-small-cell lung cancer, who received IF-RT at Kagawa University were enrolled. To evaluate the dose of incidental irradiation, we delineated nodal regions with a Japanese map and the American Thoracic Society map (levels 1-11) in each patient retrospectively and calculated the dose parameters such as mean dose, D95, and V95 (40 Gy as the prescribed dose of elective nodal irradiation).
RESULTS: Using the Japanese map, the median mean dose was more than 40 Gy in most of the nodal regions, except at levels 1, 3, and 7. In particular, each dosimetric parameter of level 1 was significantly lower than those at other levels, and each dosimetric parameter of levels 10 to 11 ipsilateral (11I) was significantly higher than those in other nodal regions. Using the American Thoracic Society map, basically, the results were similar to those of the Japanese map. ENF was observed in 4 patients (8%), five nodal regions, and no mean dose to the nodal region exceeded 40 Gy. On the Japanese map, each parameter of these five nodal region was significantly lower than those of the other nodal regions.
CONCLUSIONS: These results show that a high dose of incidental irradiation may contribute to the low incidence of ENF in patients who have received IF-RT. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19775827     DOI: 10.1016/j.ijrobp.2009.05.039

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Simultaneous integrated boost intensity-modulated radiotherapy for treatment of locally advanced non-small-cell lung cancer: a retrospective clinical study.

Authors:  K Ji; L J Zhao; W S Liu; Z Y Liu; Z Y Yuan; Q S Pang; J Wang; P Wang
Journal:  Br J Radiol       Date:  2014-01-27       Impact factor: 3.039

2.  Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer.

Authors:  Shervin M Shirvani; Ritsuko Komaki; John V Heymach; Frank V Fossella; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-12       Impact factor: 7.038

3.  Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with non-small-cell lung cancer: a study of 2062 cases.

Authors:  Y-X Wang; B-Sh Li; W Huang; Y Yi; J Zhang; Zh-T Wang; H-F Sun; H-Sh Li; Y-M Wei
Journal:  Br J Radiol       Date:  2015-06-30       Impact factor: 3.039

Review 4.  Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.

Authors:  Matthew M Yeh; Raymond S Yeung; Smith Apisarnthanarax; Renuka Bhattacharya; Carlos Cuevas; William P Harris; Tony Lim Kiat Hon; Siddharth A Padia; James O Park; Kevin M Riggle; Sayed S Daoud
Journal:  World J Hepatol       Date:  2015-06-18

5.  Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study.

Authors:  Aparna H Kesarwala; Christine J Ko; Holly Ning; Eric Xanthopoulos; Karl E Haglund; William P O'Meara; Charles B Simone; Ramesh Rengan
Journal:  Clin Lung Cancer       Date:  2014-12-09       Impact factor: 4.785

6.  Systematic Endobronchial Ultrasound-guided Mediastinal Staging Versus Positron Emission Tomography for Comprehensive Mediastinal Staging in NSCLC Before Radical Radiotherapy of Non-small Cell Lung Cancer: A Pilot Study.

Authors:  Daniel P Steinfort; Shankar Siva; Tracy L Leong; Morgan Rose; Dishan Herath; Phillip Antippa; David L Ball; Louis B Irving
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

7.  Simultaneously modulated accelerated radiation therapy reduces severe oesophageal toxicity in concomitant chemoradiotherapy of locally advanced non-small-cell lung cancer.

Authors:  Enrique Chajon; Julien Bellec; Joël Castelli; Romain Corre; Mallorie Kerjouan; Elisabeth Le Prisé; Renaud De Crevoisier
Journal:  Br J Radiol       Date:  2015-09-28       Impact factor: 3.039

8.  Protons safely allow coverage of high-risk nodes for patients with regionally advanced non-small-cell lung cancer.

Authors:  R C Nichols; S H Huh; B S Hoppe; R H Henderson; Z Li; S Flampouri; H J D'Agostino; J D Cury; D C Pham; N P Mendenhall
Journal:  Technol Cancer Res Treat       Date:  2011-08

9.  Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis.

Authors:  Jochen Fleckenstein; Andrea Eschler; Katharina Kremp; Stephanie Kremp; Christian Rübe
Journal:  Radiat Oncol       Date:  2015-08-21       Impact factor: 3.481

10.  Simultaneous integrated dose reduction intensity-modulated radiotherapy applied to an elective nodal area of limited-stage small-cell lung cancer.

Authors:  Zhiyan Liu; Weishuai Liu; Kai Ji; Ping Wang; Xin Wang; Lujun Zhao
Journal:  Exp Ther Med       Date:  2015-10-30       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.